5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Clinical Trials Support Services Market is segmented by Phase (Phase I, Phase II, Phase III and Phase IV), Service Type and Geography
Fastest Growing Market:
The clinical trials support services market will show rapid growth due to the demand for clinical trials in the emerging markets, high R&D spending, and the increasing number of CROs and prevalence of diseases.
In emerging countries, there are numerous unmet needs of clinical trials for novel drugs, due to the increasing prevalence of infectious and tropical diseases in the region. The number of individuals suffering from insulin resistance, hyperlipidemia, and obesity is increasing rapidly in these regions and, the cost of conducting clinical trials is relatively cheaper, due to fewer labor costs and low costs for handling clinical trial supplies. Thus the demand for clinical trials in emerging countries is expected to drive the clinical trials support services market’s growth over the forecast period.
The research and development (R&D) spending of pharmaceutical companies has also been steadily increasing over the past few years. This was mainly due to numerous patent expiries, and as a result of the patent expiration, there are many pharmaceutical companies that will have no other option but to develop new revolutionary molecules for survival. Therefore, the companies are spending more on R&D to accelerate the development of drugs through clinical trials, and henceforth increasing the overall market.
As per the scope of the report, clinical trial support services are the various services, which pharmaceutical companies use during the clinical trials they conduct, either for the approval of new drug molecules or for the introduction of generics and biosimilars into the market.
|By Service Type|
|Clinical Trial Site Management|
|Patient Recruitment Management|
|Packaging, Storage and Distribution Services|
|Other Service Types|
Report scope can be customized per your requirements. Click here.
Clinical trials support services for phase-I include services, like early-phase patient screening, sample collection management, data management, and assay redesign services, among others. The United States, Europe, and China, followed by Canada and Australia are thus found to be the major hubs, where a large set of Phase-I clinical trials are being registered and conducted. Thus, it is a major market for clinical trial management services.
Despite the trend of outsourcing, the developing countries host a significantly small fraction of Phase I trials. Thus, owing to the aforementioned factors, along with rising Health spending, an increasing number of Investigative New Drugs (IND) applications filed and the trend of outsourcing plays a major role in the drug development process, which is expected to propel the market growth.
To understand key trends, Download Sample Report
North America is found to be one of the largest markets for global clinical trial support services owing to the maximum number of pharmaceutical firms based in the United States to conduct most of their business in this region. There are also increasing R&D investments and growing demand for drug development that are the main factors for the growth of the overall market.
Moreover, owing to the trend of clinical trial outsourcing, the clinical trial site management services, for managing offshore operations have witnessed rapid growth.
To understand geography trends, Download Sample Report.
Product launches, partnerships, collaborations, agreements, and market expansions were the key strategies adopted by players to grow and expand their presence in the clinical trial support services market. The major players include Alcura Health, Charles River Laboratories, Laboratory Corporation of America Holdings (Covance Inc.), Eurofins Scientific, ICON PLC, Parexel International, PPD Inc., WuXi PharmaTech, etc.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demand for Clinical Trials in the Emerging Markets
4.2.2 High R&D Spending of Pharmaceutical Companies
4.2.3 Increasing Number of CROs and Prevalence of Diseases
4.3 Market Restraints
4.3.1 Lack of Adequate Regulatory Framework for Conducting Clinical Trials in some Countries
4.3.2 Stringent Regulations for Patient Enrollment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Phase
5.1.1 Phase I
5.1.2 Phase II
5.1.3 Phase III
5.1.4 Phase IV
5.2 By Service Type
5.2.1 Clinical Trial Site Management
5.2.2 Patient Recruitment Management
5.2.3 Assay Development
5.2.4 Contract Manufacturing
5.2.5 Packaging, Storage and Distribution Services
5.2.7 Other Service Types
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle-East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Charles River Laboratories, Inc.
6.1.2 Eurofins Scientific
6.1.3 Laboratory Corporation of America Holdings (Covance Inc.)
6.1.4 PPD Inc.
6.1.5 Alcura Health
6.1.6 Insight Genetics
6.1.7 Parexel International
6.1.8 Icon PLC
6.1.10 WuXi AppTec
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments